Page last updated: 2024-09-03
l 158809 and pd 145065
l 158809 has been researched along with pd 145065 in 1 studies
Compound Research Comparison
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 76 | 1 | 5 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N | 1 |
Other Studies
1 other study(ies) available for l 158809 and pd 145065
| Article | Year |
|---|---|
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles | 2001 |